Lineage Cell Therapeutics In shares owned by Rhumbline Advisers
Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by Rhumbline Advisers
from 13F filings
Historical chart of Rhumbline Advisers investment in Lineage Cell Therapeutics In
Tip: Access up to 7 years of quarterly data
All positions including Lineage Cell Therapeutics In held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Lineage Cell Therapeutics In by Rhumbline Advisers
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $170k | 115k | 1.48 |
| 2023-12-31 | $122k | 112k | 1.09 |
| 2023-09-30 | $131k | 111k | 1.18 |
| 2023-06-30 | $147k | 104k | 1.41 |
| 2022-03-31 | $157k | 102k | 1.54 |
| 2021-12-31 | $295k | 120k | 2.45 |
| 2021-09-30 | $299k | 119k | 2.52 |
| 2021-06-30 | $321k | 113k | 2.85 |
| 2020-03-31 | $149k | 180k | 0.83 |
| 2019-12-31 | $161k | 180k | 0.89 |
| 2019-09-30 | $177k | 180k | 0.98 |